Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study REPLY

被引：0
|
作者：
Derweesh, Ithaar H. [1 ]
Stroup, Sean P. [1 ]
Millard, Frederick [2 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Surg, Div Urol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Internal Med, Div Med Oncol, La Jolla, CA 92093 USA
来源：
UROLOGY | 2013年 / 81卷 / 04期
关键词：
D O I：
10.1016/j.urology.2012.10.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 812
页数：1
相关论文
共 50 条
  • [1] Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study
    Stroup, Sean P.
    Raheem, Omer A.
    Palazzi, Kerrin L.
    Liss, Michael A.
    Mehrazin, Reza
    Kopp, Ryan P.
    Patel, Nishant
    Cohen, Seth A.
    Park, Samuel K.
    Patterson, Anthony L.
    Kane, Christopher J.
    Millard, Frederick
    Derweesh, Ithaar H.
    UROLOGY, 2013, 81 (04) : 805 - 811
  • [2] DOES TIMING OF CYTOREDUCTIVE NEPHRECTOMY IMPACT PATIENT SURVIVAL WITH METASTATIC RENAL CELL CARCINOMA IN THE TYROSINE KINASE INHIBITOR ERA?
    Stroup, Sean
    Raheem, Omer
    Kopp, Ryan
    Palazzi-Churas, Kerrin
    Mehrazin, Reza
    Millard, Fred
    Patterson, Anthony
    Derweesh, Ithaar
    JOURNAL OF UROLOGY, 2011, 185 (04): : E713 - E713
  • [3] Trends in the use of cytoreductive nephrectomy for metastatic renal cell carcinoma in the VEGFR tyrosine kinase inhibitor era
    Tsao, Che-Kai
    Small, Alexander C.
    Kates, Max
    Gartrell, Benjamin Adam
    Wisnivesky, Juan P.
    Sonpavde, Guru
    Palese, Michael
    Hall, Simon
    Oh, William K.
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Cytoreductive Nephrectomy in Metastatic Clear-Cell Renal Cell Carcinoma: Perspectives in the Tyrosine Kinase Inhibitor Era
    Biswas, Swethajit
    Kelly, John
    Eisen, Tim
    ONCOLOGIST, 2009, 14 (01): : 52 - 59
  • [5] TIMING OF CYTOREDUCTIVE NEPHRECTOMY DOES NOT INFLUENCE SURVIVAL IN METASTATIC RENAL CELL CARCINOMA
    Chapin, Brian F.
    Delacroix, Scott E.
    Culp, Stephen H.
    Nogueras-Gonzalez, Graciela M.
    Tannir, Nizar
    Jonasch, Eric
    Tamboli, Pheroz
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E705 - E706
  • [6] Impact of tyrosine kinase inhibitors and cytoreductive nephrectomy in patients with metastatic renal cell carcinoma
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (04): : 292 - 292
  • [7] SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR
    Lo, Jing Zhi
    Sunaryo, Peter
    Paulucci, David
    Badani, Ketan
    JOURNAL OF UROLOGY, 2018, 199 (04): : E867 - E867
  • [8] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study
    Kato, Renpei
    Naito, Sei
    Numakura, Kazuyuki
    Hatakeyama, Shingo
    Koguchi, Tomoyuki
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Kandori, Shuya
    Kawamura, Sadafumi
    Arai, Yoichi
    Ito, Akihiro
    Nishiyama, Hiroyuki
    Kojima, Yoshiyuki
    Ohyama, Chikara
    Habuchi, Tomonori
    Tsuchiya, Norihiko
    Obara, Wataru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (03) : 563 - 573
  • [9] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
    Renpei Kato
    Sei Naito
    Kazuyuki Numakura
    Shingo Hatakeyama
    Tomoyuki Koguchi
    Takahiro Kojima
    Yoshihide Kawasaki
    Shuya Kandori
    Sadafumi Kawamura
    Yoichi Arai
    Akihiro Ito
    Hiroyuki Nishiyama
    Yoshiyuki Kojima
    Chikara Ohyama
    Tomonori Habuchi
    Norihiko Tsuchiya
    Wataru Obara
    International Journal of Clinical Oncology, 2022, 27 : 563 - 573
  • [10] The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis
    Ghatalia, Pooja
    Handorf, Elizabeth A.
    Geynisman, Daniel M.
    Deng, Mengying
    Zibelman, Matthew R.
    Abbosh, Philip
    Anari, Fern
    Greenberg, Richard E.
    Viterbo, Rosalia
    Chen, David
    Smaldone, Marc C.
    Kutikov, Alexander
    Uzzo, Robert G.
    JOURNAL OF UROLOGY, 2022, 208 (01): : 71 - 79
12345